Actinomycetes produce about two-thirds of all known antibiotics of microbial origin, and remain an important source of potentially clinically useful compounds. These include ribosomally synthesised and post-translationally modified peptides (RiPPs). Using genome mining, we have isolated and characterised gene clusters responsible for the biosynthesis of the RiPPs cinnamycin, microbisporicin, cypemycin, venezuelin, bottromycin and planosporicin. This presentation will describe experiments that have revealed novel enzymology, novel regulatory mechanisms, a novel mechanism of immunity, and a crucial role for immunity in regulating the onset of antibiotic biosynthesis; evidence will also be presented that suggests that at least some RiPPs serve as signalling molecules to induce their own synthesis.
